Prolongation of the QTc interval in African children treated for falciparum malaria.

Prolongation of the QTc interval in African children treated for falciparum malaria.

Mostra altre versioni (1)

Dettagli Bibliografici
Autori principali:	Price, R, Nosten, F, White, N
Natura:	Journal article
Lingua:	English
Pubblicazione:	1998

Documenti analoghi

Prolongation of the QTc interval in African children treated for falciparum malaria
di: Price, R, et al.
Pubblicazione: (1998)

QTc Prolongation and Ventricular Trigemini with Asenapine: A Case Report
di: Gill, Jesjeet Singh, et al.
Pubblicazione: (2017)

Letter by Herring and Paterson regarding article, "Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study".
di: Herring, N, et al.
Pubblicazione: (2007)

Combining an in silico proarrhythmic risk assay with a tPKPD model to predict QTc interval prolongation in the anesthetized guinea pig assay
di: Morissette, P, et al.
Pubblicazione: (2020)

Effect of Age and Sex on the QTc Interval in Children and Adolescents With Type 1 and 2 Long-QT Syndrome
di: Vink, A, et al.
Pubblicazione: (2017)

Pathophysiology of fatal falciparum malaria in African children.
di: Newton, C, et al.
Pubblicazione: (1998)

Neurological features of falciparum malaria in African children
di: Idro, R, et al.
Pubblicazione: (2006)

Management of severe falciparum malaria in African children.
di: Newton, C
Pubblicazione: (2004)

Does artesunate prolong the electrocardiograph QT interval in patients with severe malaria?
di: Maude, R, et al.
Pubblicazione: (2009)

Parenteral chloroquine for treating falciparum malaria.
di: White, N, et al.
Pubblicazione: (1987)

Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives.
di: Price, R, et al.
Pubblicazione: (1999)

Absorption of intramuscular phenobarbitone in children with severe falciparum malaria.
di: Kuile, F, et al.
Pubblicazione: (1992)

MEFLOQUINE PHARMACOKINETICS AND RESISTANCE IN CHILDREN WITH ACUTE FALCIPARUM-MALARIA
di: Nosten, E, et al.
Pubblicazione: (1991)

DISPERSI QTc (QTcD) SEBAGAI UJI SARING MORBIDITAS JANTUNG PADA PENDERITA THALASSEMIA ANAK-ANAK
di: , Intan Patah Kumara, et al.
Pubblicazione: (2012)

Pharmacokinetics of mefloquine combined with artesunate in children with acute falciparum malaria.
di: Price, R, et al.
Pubblicazione: (1999)

The genetic risk of acute seizures in African children with falciparum malaria.
di: Kariuki, S, et al.
Pubblicazione: (2013)

Symptomatic illness and treatment of Plasmodium falciparum malaria in African children
di: Dalrymple, U
Pubblicazione: (2018)

Mefloquine pharmacokinetics and resistance in children with acute falciparum malaria.
di: Nosten, F, et al.
Pubblicazione: (1991)

Artemisinin-based combination treatment of falciparum malaria.
di: Nosten, F, et al.
Pubblicazione: (2007)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine
di: Zongo, I, et al.
Pubblicazione: (2014)

Persistence of Plasmodium falciparum HRP-2 in successfully treated acute falciparum malaria.
di: Mayxay, M, et al.
Pubblicazione: (2001)

Hypoglycaemia in African children with severe malaria.
di: White, N, et al.
Pubblicazione: (1987)

WILL REDUCING PLASMODIUM-FALCIPARUM TRANSMISSION ALTER MALARIA MORTALITY AMONG AFRICAN CHILDREN
di: Snow, R, et al.
Pubblicazione: (1995)

Falciparum malaria in pregnancy.
di: Mcgready, R, et al.
Pubblicazione: (1995)

The influence of alanine infusion on glucose production in 'malnourished' African children with falciparum malaria.
di: Dekker, E, et al.
Pubblicazione: (1997)

Drugs that reduce transmission of falciparum malaria.
di: Price, R, et al.
Pubblicazione: (2018)

Artemisinin Resistance in Plasmodium falciparum Malaria REPLY
di: Dondorp, A, et al.
Pubblicazione: (2009)

Quantifying the contribution of Plasmodium falciparum malaria to febrile illness amongst African children
di: Dalrymple, U, et al.
Pubblicazione: (2017)

Quantifying the contribution of Plasmodium falciparum malaria to febrile illness amongst African children
di: Dalrymple, U, et al.
Pubblicazione: (2017)

Drug resistant falciparum malaria: clinical consequences and strategies for prevention.
di: Price, R, et al.
Pubblicazione: (2001)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
di: Tarning, J, et al.
Pubblicazione: (2012)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
di: Tarning, J, et al.
Pubblicazione: (2012)

Cost of treating inpatient falciparum malaria on the Thai-Myanmar border
di: Kyaw, S, et al.
Pubblicazione: (2014)

Glucose metabolism in quinine-treated patients with uncomplicated falciparum malaria.
di: Davis, T, et al.
Pubblicazione: (1990)

Artesunate for severe malaria in African children Reply
di: Dondorp, A, et al.
Pubblicazione: (2011)

Overview of non-falciparum malaria in nonpregnant adults and children
di: Baird, J, et al.
Pubblicazione: (2016)

Factors affecting haemoglobin dynamics in African children with acute uncomplicated Plasmodium falciparum malaria treated with single low-dose primaquine or placebo
di: Onyamboko, MA, et al.
Pubblicazione: (2023)

Post-treatment haemolysis in African children with hyperparasitaemic falciparum malaria; a randomized comparison of artesunate and quinine
di: Fanello, C, et al.
Pubblicazione: (2017)

A case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant Plasmodium falciparum malaria.
di: Van Vugt, M, et al.
Pubblicazione: (2000)

Conflicting immune responses can prolong the length of infection in Plasmodium falciparum malaria.
di: Recker, M, et al.
Pubblicazione: (2006)